纳米载体的最新进展封装了肉酸及其衍生物作为有希望的抗癌剂
Nadine Wafik Nabih1, Mohamed S Nafie2,3, Asaad Babker4
1Organic and Medicinal Chemistry Department, Faculty of Pharmacy, University of Sadat City Sadat City Menoufia 32897 Egypt.
RSC advances
|June 23, 2025
概括
肉酸显示抗癌承诺,但溶解性差限制了它的使用. 纳米技术通过改善这种天然化合物在癌症治疗中的传递和增强其治疗潜力来提供解决方案.
科学领域:
- 自然产品化学 自然产品化学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 尽管有进展,但癌症治疗仍面临诸如耐药性和毒性等挑战.
- 自然衍生化合物,如肉中的肉酸,表现出抗瘤特性.
- 诸如肉酸之类的植物化学物质往往具有较差的溶解性和生物可用性,阻碍了临床应用.
研究的目的:
- 审查纳米配制肉酸及其衍生物的最新进展.
- 探索纳米载体如何克服肉酸在癌症治疗中的局限性.
- 评估纳米配方肉酸在临床前癌症模型中的增强治疗潜力.
主要方法:
- 对最近关于肉酸纳米配方研究的文献综述.
- 对用于酸输送的各种纳米载体系统的分析.
- 对纳米配方肉酸的疗效和安全性进行了体外和体内数据的评估.
主要成果:
- 已经开发了各种纳米载体系统,包括纳米颗粒,脂质体和小粒,用于酸.
- 纳米配方显著改善了酸的可溶性,生物可用性和药用动力学特征.
- 在体外和体内研究表明,与免费药物相比,纳米配制的肉酸具有增强的抗癌活性和降低的毒性.
结论:
- 纳米配方是一种有前途的策略,可以增强肉酸作为抗癌剂的临床效用.
- 纳米载体有效地解决了与肉酸相关的输送挑战,改善了其治疗指数.
- 对优化纳米配方的进一步研究可能会导致新的,更安全的癌症疗法.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
366
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K


